Nicholas Keen's most recent trade in Bicycle Therapeutics Plc - ADR was a trade of 779 Ordinary Shares done at an average price of $19.6 . Disclosure was reported to the exchange on July 3, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bicycle Therapeutics Plc -... | Nicholas Keen | CHIEF SCIENTIFIC OFFICER | 03 Jul 2024 | 779 | 62,024 | - | 19.6 | 15,300 | Ordinary Shares | |
| Bicycle Therapeutics Plc -... | Nicholas Keen | CHIEF SCIENTIFIC OFFICER | 03 Apr 2024 | 790 | 62,803 | - | 23.8 | 18,810 | Ordinary Shares | |
| Bicycle Therapeutics Plc -... | Nicholas Keen | Chief Scientific Officer | 02 Jan 2024 | 56,000 | 56,000 | - | - | Employee Stock Option (right to buy) | ||
| Bicycle Therapeutics Plc -... | Nicholas Keen | Chief Scientific Officer | 02 Jan 2024 | 28,000 | 66,233 | - | 0 | Ordinary Shares | ||
| Bicycle Therapeutics Plc -... | Nicholas Keen | Chief Scientific Officer | 02 Jan 2024 | 2,640 | 63,593 | - | 17.5 | 46,200 | Ordinary Shares |